SL-251131
SL-251131 is a reversible non-specific MAO inhibitor. SL-251131 temporarily blocks both MAO-A and MAO-B enzymes, which are responsible for breaking down neurotransmitters like dopamine. SL-251131 can be used for the study of Parkinson's disease[1].
Product Specifications
CAS Number
[176773-86-7]
UNSPSC
12352005
Target
Monoamine Oxidase
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
Smiles
O=C1N2C3=CC=C(OCCCC(F)(F)F)C=C3CC[C@@]2([H])[C@H](O1)COC
Molecular Formula
C17H20F3NO4
Molecular Weight
359.34
References & Citations
[1]Korczyn AD, Nussbaum M. Emerging therapies in the pharmacological treatment of Parkinson’s disease. Drugs. 2002 Apr;62 (5) :775-86.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
122919-HRP 100 µL
Activating Transcription Factor 3 (ATF3, ATF-3, Cyclic AMP-dependent Transcription Factor ATF-3, cAMP-dependent Transcription Factor ATF-3) (HRP)
Ask
View Details